Literature DB >> 9102205

Low incidence of p53 mutations in UVA (365-nm)-induced skin tumors in hairless mice.

H J van Kranen1, A de Laat, J van de Ven, P W Wester, A de Vries, R J Berg, C F van Kreijl, F R de Gruijl.   

Abstract

Mutations with clear "UVB fingerprints" have been observed in the p53 gene of human nonmelanoma skin tumors and of experimentally UVB-induced murine skin tumors. Although UVA (315-400 nm) radiation is also a complete carcinogen, its contribution to sunlight-induced mutagenesis remains poorly characterized. There is experimental evidence that the production of reactive oxygen species plays a more dominant role with long-wave UVA than with UVB radiation. We have induced skin tumors (n = 42) in hairless SKH:HR1 mice (n = 14) by daily exposure to long-wave UVA (365-nm) radiation. The incidence of p53 alterations in these tumors is low compared to UVB-induced tumors; positive staining for the p53 protein was observed in only 50% of the tumors, and less than 15% of the tumors showed a mutation in one of the exons 5, 7, or 8 of the p53 gene. The pattern of p53 staining was more irregular and less dense compared to UVB, and the mutations (all C-->T) were mainly (six of seven) located at codon 267. Besides a general p53 hotspot, this codon is also the main hotspot for UVB-induced skin tumors in these mice. No mutations specific for UVA, ie., mutations specific for reactive oxygen species, could be detected.

Entities:  

Mesh:

Year:  1997        PMID: 9102205

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Mutagenicity of ultraviolet A radiation in the lacI transgene in Big Blue mouse embryonic fibroblasts.

Authors:  Sang-in Kim; Gerd P Pfeifer; Ahmad Besaratinia
Journal:  Mutat Res       Date:  2007-01-10       Impact factor: 2.433

2.  Revisiting the photochemistry of solar UVA in human skin.

Authors:  David Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-05       Impact factor: 11.205

3.  Activation of p38 MAP kinase and JNK pathways by UVA irradiation.

Authors:  Jack Zhang; G Tim Bowden
Journal:  Photochem Photobiol Sci       Date:  2011-08-22       Impact factor: 3.982

4.  Nucleolin stabilizes Bcl-X L messenger RNA in response to UVA irradiation.

Authors:  Jack Zhang; George Tsaprailis; G Tim Bowden
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

5.  Suppression of PTEN transcription by UVA.

Authors:  Baozhong Zhao; Mei Ming; Yu-Ying He
Journal:  J Biochem Mol Toxicol       Date:  2012-11-05       Impact factor: 3.642

6.  The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis.

Authors:  Nita S Agar; Gary M Halliday; Ross StC Barnetson; Honnavara N Ananthaswamy; Mark Wheeler; Alexandra M Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-23       Impact factor: 11.205

7.  Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.

Authors:  C H Hsu; S A Yang; J Y Wang; H S Yu; S R Lin
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

8.  Fractionation of a tumor-initiating UV dose introduces DNA damage-retaining cells in hairless mouse skin and renders subsequent TPA-promoted tumors non-regressing.

Authors:  Gerline van de Glind; Heggert Rebel; Marika van Kempen; Kees Tensen; Frank de Gruijl
Journal:  Oncotarget       Date:  2016-02-16

Review 9.  The Damaging Effects of Long UVA (UVA1) Rays: A Major Challenge to Preserve Skin Health and Integrity.

Authors:  Françoise Bernerd; Thierry Passeron; Isabelle Castiel; Claire Marionnet
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

10.  Nrf2 null enhances UVB-induced skin inflammation and extracellular matrix damages.

Authors:  Constance Lay Lay Saw; Anne Yuqing Yang; Mou-Tuan Huang; Yue Liu; Jong Hun Lee; Tin Oo Khor; Zheng-Yuan Su; Limin Shu; Yaoping Lu; Allan H Conney; Ah-Ng Tony Kong
Journal:  Cell Biosci       Date:  2014-08-05       Impact factor: 7.133

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.